Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates

References

Page 1

	Year	Citations
Performance standards for antimicrobial susceptibility testing Mary Jane Ferraro Antimicrobial SusceptibilityHealth SciencesAntibioticsMicrobiologyInfection Control	2001	9.8K
Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia George Sakoulas, Pamela A. Moise-Broder, Jerome J. Schentag, Journal of Clinical Microbiology	2004	834
Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia Àlex Soriano, Francesc Marco, J. A. Martínez, Clinical Infectious Diseases	2007	764
Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia Treated with Vancomycin Thomas P. Lodise, Jeffrey Graves, A. Evans, Antimicrobial Agents and Chemotherapy Mrsa CultureMrsa BacteremiaAntibiotic ResistanceVancomycin MicDrug Resistance	2008	551
Treatment Outcomes for Serious Infections Caused by Methicillin‐Resistant<i>Staphylococcus aureus</i>with Reduced Vancomycin Susceptibility Benjamin P. Howden, Peter Ward, Patrick G. P. Charles, Clinical Infectious Diseases Antimicrobial ChemotherapyReduced Vancomycin SusceptibilityAntibiotic ResistanceDrug ResistanceHealthcare-associated Infection	2004	483
Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate <i>Staphylococcus aureus</i> Longzhu Cui, Eiji Tominaga, Hui‐min Neoh, Antimicrobial Agents and Chemotherapy	2006	431
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05 Gregory E. Steinkraus, Roger L. White, Lawrence V. Friedrich Journal of Antimicrobial Chemotherapy	2007	418
A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital Mandy Wootton Journal of Antimicrobial Chemotherapy Staphylococcus AureusPathologyVancomycin-resistant S. AureusAntibiotic ResistanceDrug Resistance	2001	404
Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin‐Intermediate<i>Staphylococcus aureus</i> Patrick G. P. Charles, Peter Ward, Paul D. R. Johnson, Clinical Infectious Diseases Vancomycin-susceptible MrsaPersistent FeverAntimicrobial SusceptibilityHealth SciencesAntimicrobial Stewardship	2004	382
Increased Vancomycin MICs for <i>Staphylococcus aureus</i> Clinical Isolates from a University Hospital during a 5-Year Period Guiqing Wang, Janet Hindler, Kevin W. Ward, Journal of Clinical Microbiology 5-Year PeriodVancomycin Mic ShiftVancomycin MicHospital MedicineDrug Resistance	2006	357

Page 1